close

Enter

Log in using OpenID

Facial Rejuvenation Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2029

embed
Global Facial Rejuvenation Market is estimated to value over USD 25.10 billion by 2026 end and is projected to register a CAGR of 4.9% during the forecast period 2018 to 2026. The cosmetic treatments that require minimally invasive procedures are ga
Facial Rejuvenation Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2029
Global Facial Rejuvenation Market is estimated to value over USD 25.10 billion by
2026 end and is projected to register a CAGR of 4.9% during the forecast period 2018
to 2026. The cosmetic treatments that require minimally invasive procedures are
gaining popularity thus resulting in the proliferation of the facial rejuvenation
market. There is a growing demand for aesthetic treatment especially from the
female patient population which has further augmented the market significantly.
Several cosmetic companies are taking efforts in expanding their market by
introducing advanced treatments for nasal folds, forehead lines, glabellar lines,
wrinkles through products like botulinum and dermal fillers which has boosted the
market growth further.
FDA has approved absorbable dermal fillers for cheek and lip augmentation and
contour deficiencies in patients over the age of 21 which shall prove instrumental for
the market to grow significantly.
The botulinum toxin segment accounts for around 1/3rd of the total facial
rejuvenation treatment revenue share owing to its high usage especially among
models and celebrities who need to keep their skin tight to look young. Furthermore,
portable laser-based devices integrated with topical skincare products have
witnessed increased adoption which has boosted the market growth further.
The hospital segment accounts for the highest market share owing to the premium
quality of infrastructure that hospitals offer. Additionally, with the introduction of
multispecialty hospitals, the acquisition of the patient population has significantly
increased thus assisting the facial rejuvenation market to thrive.
However, emerging economies like India and China have a majority of the population
in the lower-middle-class category that cannot afford before-mentioned high
expenditures which is why dermatology clinics are preferred for facial rejuvenation
treatments in these countries.
North America to Hold Highest Market Share
The North American region is expected to account for the highest market share and
strengthen its market position in terms of revenue owing to a rise in the number of
female patient population pursuing anti-ageing solutions. Some of the factors
responsible for the market to flourish in this region are low treatment costs and high
demand for facial rejuvenation products to look young.
Europe is the second-largest market after North America owing to the increase in
several minimally-invasive procedures coupled with a population that is rapidly
ageing due to lifestyle choices like smoking cigarettes, drinking alcohol, etc.
Additionally, these non-invasive treatments are cost-effective which has increased
their adoption in this region.
Facial rejuvenation product manufacturers are collaborating and merging with
various local facial rejuvenation product manufacturers to strengthen their market
position. For instance, in 2017, Merz and Teijin partnered to bring Xeomin to Japan.
The Latin American region is projected to exhibit a significant market growth during
the forecast period owing to cost-effective treatments offered to the patient
population of this region. This is also the case with the Asia Pacific region as a
majority of the patient population is lower-middle-class who can afford such
treatments.
Key Market Players:
• Allergen Plc
• Merz GmbH
• Nestle Skin Health
• Bosch Pharmaceuticals
Allergen has a strong product line up in dermal filler and botulinum toxin segment.
The company has initiated to expand their geographical reach beyond the U.S market
and this has been made possible with the launch of new product line ups. The
company launched Juvederm Volite in 2017 which can be used by adults over the age
of 21 for treating facial wrinkle and folds correction.
Key Strategy:
• One of the key developmental strategies of Allergen Plc is to obtain approvals for
their products. The primary intention of getting approvals is to gain authenticity for
their facial treatment products so as to target potential market regions like Asia
Pacific and Latin America
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=48&page=requestsample
1. By Product Type
• Botulinum Toxin (BOTOX)
•
o
o
o
Soft Tissue Fillers
Short-term Fillers
Medium-term Fillers
Long-term Fillers
• Micro abrasion Equipment
• Chemical Peels
• Topical Skin Care Products
•
o
o
o
o
Skin Rejuvenation Devices
Intense Pulsed Light
Microdermabrasion
Laser-based Devices
Ultrasound
2.
•
•
•
By End User
Hospitals
Dermatology Clinics
Beauty Centres & Spa
3. By Region
• North America
• Asia Pacific
• Latin America
• Europe
• Rest of the World
Purchase a Copy & Ask For Discount:
https://www.futurewiseresearch.com/requestsample.aspx?id=48&page=askfordiscount
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the facial rejuvenation market by
region, by product type, by end user
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America,
Asia Pacific, Latin America, Europe and rest of the world
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
Table of Contents
1. Introduction
1.1. Scope and Objective
1.2. Assumption & Acronyms
1.3. Forecast Factors
1.4. Research Methodology
2. Executive Summary
2.1. Industry Cluster Analysis
2.2. Competition Matrix
2.3. Strategies Recommendations
3. Market Definition
3.1. Report Scope (Inclusions & Exclusions)
3.2. Market Segmentation
4. Global Facial Rejuvenation Market Overview
4.1. Target Market Assessment
4.2. Global Facial Rejuvenation Market Revenue (US$ Mn)
4.3. Regional Average Selling Pricing Analysis (USD), By Product Type, 2018
5. Key Inclusions
5.1. Porter’s Five Force analysis
5.2. Market Dynamics
5.3. Industry Trends
5.4. Regulatory Guidelines
6. Competition Dynamics
6.1. Top 10 Product Pricing by Region
6.2. Commercial Adoption at Medical Tourism Nations
7. Global Facial Rejuvenation Market Revenue (US$ Mn) & Volume (Units), 20182026 by Product Type
7.1. Key Market Findings
7.2. Long Term ROI Segments
7.3. Revenue Opportunity Influencing Factors
7.4. Market Revenue (US$ Mn) Assessment and Forecast by Product Type, 20182026
7.4.1. Botulinum Toxin
7.4.2. Soft tissue fillers
7.4.2.1.
Short-term Fillers
7.4.2.2.
Medium-term Fillers
7.4.2.3.
Long-term Fillers
7.4.3. Chemical Peels
7.4.4. Topical Skin Care Products
7.4.5. Skin Rejuvenation Devices
7.4.5.1.
Intense Pulsed Light
7.4.5.2.
Microdermabrasion
7.4.5.4.
Ultrasound
8. Global Facial Rejuvenation Market Revenue (US$ Mn), 2018-2026 by End User
8.1. Key Market Findings
8.2. Long Term ROI Segments
8.3. Revenue Opportunity Influencing Factors
8.4. Market Revenue (US$ Mn) Assessment and Forecast by End User, 2018-2026
8.4.1. Hospitals
8.4.2. Dermatology Clinics
8.4.3. Beauty Centres & Spas
9. Global Facial Rejuvenation Market Revenue (US$ Mn) & Volume (Units), 20182026 by Region
9.1. Key Market Findings
9.2. Long Term ROI Segments
9.3. Revenue Opportunity Influencing Factors
9.4. Market Revenue (US$ Mn) Assessment and Forecast by Region, 2018-2026
9.4.1. North America
9.4.2. Latin America
9.4.3. Europe
9.4.4. Asia Pacific
9.4.5. Rest of World
10. North America Facial Rejuvenation Market Revenue (US$ Mn), 2018-2026
10.1.
Key Market Findings
10.2.
Long Term ROI Segments
10.3.
Revenue Opportunity Influencing Factors
10.4.
2026
Market Revenue (US$ Mn) Assessment and Forecast by Country, 2018-
10.4.1. US
10.4.2. Canada
10.5.
Market Revenue (US$ Mn) Assessment and Forecast by Product Type,
2018-2026
10.5.1. Botulinum Toxin
10.5.2. Soft tissue fillers
10.5.2.1.
Short-term Fillers
10.5.2.2.
Medium-term Fillers
10.5.2.3.
Long-term Fillers
10.5.3. Chemical Peels
10.5.4. Topical Skin Care Products
10.5.5. Skin Rejuvenation Devices
10.5.5.1.
Intense Pulsed Light
10.5.5.2.
Microdermabrasion
10.5.5.3.
Laser Based Devices
10.5.5.4.
Ultrasound
10.6.
2026
Market Revenue (US$ Mn) Assessment and Forecast by End User, 2018-
10.6.1. Hospitals
10.6.2. Dermatology Clinics
10.6.3. Beauty Centres & Spas
11. Latin America Facial Rejuvenation Market Revenue (US$ Mn) & Volume (Units),
2018-2026
11.1.
Key Market Findings
11.2.
Long Term ROI Segments
11.3.
Revenue Opportunity Influencing Factors
11.4.
2026
Market Revenue (US$ Mn) Assessment and Forecast by Country, 2018-
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of Latin America
11.5.
Market Revenue (US$ Mn) Assessment and Forecast by Product Type,
2018-2026
11.5.1. Botulinum Toxin
11.5.2. Soft tissue fillers
11.5.2.1.
Short-term Fillers
11.5.2.2.
Medium-term Fillers
11.5.2.3.
Long-term Fillers
11.5.3. Chemical Peels
11.5.4. Topical Skin Care Products
11.5.5. Skin Rejuvenation Devices
11.5.5.1.
Intense Pulsed Light
11.5.5.2.
Microdermabrasion
11.5.5.3.
Laser Based Devices
11.5.5.4.
Ultrasound
11.6.
2026
Market Revenue (US$ Mn) Assessment and Forecast by End User, 2018-
11.6.1. Hospitals
11.6.2. Dermatology Clinics
11.6.3. Beauty Centres & Spas
12. Europe Facial Rejuvenation Market Revenue (US$ Mn) & Volume (Units), 20182026
12.1.
Key Market Findings
12.2.
Long Term ROI Segments
12.3.
Revenue Opportunity Influencing Factors
12.4.
2026
Market Revenue (US$ Mn) Assessment and Forecast by Country, 2018-
12.4.1. Germany
12.4.2. France
12.4.3. Spain
12.4.4. UK
12.4.5. Russia
12.4.6. Poland
12.4.7. Rest of Europe
12.5. Market Revenue (US$ Mn) Assessment and Forecast by Product Type, 20182026
12.5.1. Botulinum Toxin
12.5.2. Soft tissue fillers
12.5.2.1.
Short-term Fillers
12.5.2.2.
Medium-term Fillers
12.5.2.3.
Long-term Fillers
12.5.3. Chemical Peels
12.5.4. Topical Skin Care Products
12.5.5. Skin Rejuvenation Devices
12.5.5.1.
Intense Pulsed Light
12.5.5.2.
Microdermabrasion
12.5.5.3.
Laser Based Devices
12.5.5.4.
Ultrasound
12.6.
2026
Market Revenue (US$ Mn) Assessment and Forecast by End User, 2018-
12.6.1. Hospitals
12.6.2. Dermatology Clinics
12.6.3. Beauty Centres & Spas
13. Asia-Pacific Facial Rejuvenation Market Revenue (US$ Mn) & Volume (Units),
2018-2026
13.1.
Key Market Findings
13.2.
Long Term ROI Segments
13.3.
Revenue Opportunity Influencing Factors
13.4.
2026
Market Revenue (US$ Mn) Assessment and Forecast by Country, 2018-
13.4.1. Emerging Asia
13.4.1.1.
China
13.4.1.2.
India
13.4.1.3.
ASEAN-5
13.4.1.4.
Rest of Emerging Asia
13.4.2. Japan
13.4.3. Australia & New Zealand
13.4.4. Rest of Asia-Pacific
13.5.
Market Revenue (US$ Mn) Assessment and Forecast by Product Type,
2018-2026
13.5.1. Botulinum Toxin
13.5.2. Soft tissue fillers
13.5.2.1.
Short-term Fillers
13.5.2.2.
Medium-term Fillers
13.5.2.3.
Long-term Fillers
13.5.3. Chemical Peels
13.5.4. Topical Skin Care Products
13.5.5. Skin Rejuvenation Devices
13.5.5.1.
Intense Pulsed Light
13.5.5.2.
Microdermabrasion
13.5.5.3.
Laser Based Devices
13.5.5.4.
Ultrasound
13.6.
2026
Market Revenue (US$ Mn) Assessment and Forecast by End User, 2018-
13.6.1. Hospitals
13.6.2. Dermatology Clinics
13.6.3. Beauty Centres & Spas
14. Rest of World Facial Rejuvenation Market Revenue (US$ Mn) & Volume (Units),
2018-2026
14.1.
Key Market Findings
14.2.
Long Term ROI Segments
14.3.
Revenue Opportunity Influencing Factors
14.4.
2026
Market Revenue (US$ Mn) Assessment and Forecast by Country, 2018-
14.4.1. Middle East
14.4.2. South Africa
14.4.3. North Africa
14.4.4. Rest of World
14.5.
Market Revenue (US$ Mn) Assessment and Forecast by Product Type,
2018-2026
14.5.1. Botulinum Toxin
14.5.2. Soft tissue fillers
14.5.2.1.
Short-term Fillers
14.5.2.2.
Medium-term Fillers
14.5.2.3.
Long-term Fillers
14.5.3. Chemical Peels
14.5.4. Topical Skin Care Products
14.5.5. Skin Rejuvenation Devices
14.5.5.1.
Intense Pulsed Light
14.5.5.2.
Microdermabrasion
14.5.5.3.
Laser Based Devices
14.5.5.4.
Ultrasound
14.6.
2026
Market Revenue (US$ Mn) Assessment and Forecast by End User, 2018-
14.6.1. Hospitals
14.6.2. Dermatology Clinics
14.6.3. Beauty Centres & Spas
15. Company Profiles
15.1.
Competition Landscape
15.2.
Global Company Share (US$ Mn) Overview, 2018
15.3.
Company Profiles
15.3.1. Anika Therapeutics Inc.
15.3.1.1.
Corporate Overview
15.3.1.2.
Financial Performance
15.3.1.3.
Peer Comparison & 3C marketing equation
15.3.1.4.
Company Strategy & Channel Management
15.3.2. Merz Pharma
15.3.2.1.
Corporate Overview
15.3.2.2.
Financial Performance
15.3.2.3.
Peer Comparison & 3C marketing equation
15.3.2.4.
Company Strategy & Channel Management
15.3.3. Galderma
15.3.3.1.
Corporate Overview
15.3.3.2.
Financial Performance
15.3.3.3.
Peer Comparison & 3C marketing equation
15.3.3.4.
Company Strategy & Channel Management
15.3.4. Allergen Plc.
15.3.4.1.
Corporate Overview
15.3.4.2.
Financial Performance
15.3.4.3.
Peer Comparison & 3C marketing equation
15.3.4.4.
Company Strategy & Channel Management
15.3.5. Ipsen Group
15.3.5.1.
Corporate Overview
15.3.5.2.
Financial Performance
15.3.5.3.
Peer Comparison & 3C marketing equation
15.3.5.4.
Company Strategy & Channel Management
15.3.6. Daewoong Pharmaceuticals Co. Ltd.
15.3.6.1.
Corporate Overview
15.3.6.2.
Financial Performance
15.3.6.3.
Peer Comparison & 3C marketing equation
15.3.6.4.
Company Strategy & Channel Management
15.3.7. Cynosure
15.3.7.1.
Corporate Overview
15.3.7.2.
Financial Performance
15.3.7.3.
Peer Comparison & 3C marketing equation
15.3.7.4.
Company Strategy & Channel Management
15.3.8. Syneron
15.3.8.1.
Corporate Overview
15.3.8.2.
Financial Performance
15.3.8.3.
Peer Comparison & 3C marketing equation
15.3.8.4.
Company Strategy & Channel Management
15.3.9. Valeant Pharmaceuticals,
15.3.9.1.
Corporate Overview
15.3.9.2.
Financial Performance
15.3.9.3.
Peer Comparison & 3C marketing equation
15.3.9.4.
Company Strategy & Channel Management
15.3.10.
Sinclair Pharma
15.3.10.1. Corporate Overview
15.3.10.2. Financial Performance
15.3.10.3. Peer Comparison & 3C marketing equation
15.3.10.4. Company Strategy & Channel Management
16. Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
1/--pages
Report inappropriate content